Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

M. Levine(McMaster University), Mark N. Levine(McMaster University), J. Hirsh(McMaster University), A. Arnold(Cancer Research UK), Michael Gent(Cancer Research UK), Mark N. Levine(Cancer Research UK), M. Levine(National Cancer Centre Japan), A. Arnold(Cancer Research UK), V. Bramwell(National Cancer Centre Japan), Kathleen I. Pritchard(Regional Cancer Center), David W. Stewart(Mount Sinai Hospital), David Warr(Hotel Dieu Hospital), Pamela J. Goodwin(Mount Sinai Hospital), Martin Samosh(Hotel Dieu Hospital), Anna Falanga
The Lancet
April 1, 1994
Cited by 513

Abstract


Related Papers

No related papers found

Powered by citation graph analysis